Results of a prospective trial 1989/90 to 1999/2000 (JEVIN): Quality of life of patients with type 1 and insulin-treated type 2 diabetes mellitus in a closed population;Ergebnisse einer prospektiven untersuchung 1989/90 bis 1999/2000 (JEVIN): Die lebensqualität von patienten mit typ-1- und insulinbehandeltem typ-2-diabetes mellitus einer selektionsfreien population

Diabetes und Stoffwechsel

Volumn 12, Issue 2, 2003, Pages 95-104

  Rillig, A ^c   Muller U A ^a   Braun, Anke ^a   Leppert, Karena ^b   Schiel, Ralf ^b  

^a Klinik fur Innere Medizin IV   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c NONE

Author keywords

HbA1C; Nephropathy; Neuropathy; Quality of life; Retinopathy; Treatment satisfaction; Type 1 diabetes mellitus; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADOLESCENT; ADULT; ARTICLE; DIET RESTRICTION; FEAR; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN RELATION; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LEISURE; MAJOR CLINICAL STUDY; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL PERFORMANCE; QUALITY OF LIFE; WELLBEING;

EID: 0037457086     PISSN: 09420037     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Abreira C, Colwell JA, Nuttall FQ, Sawin CT, Nagel NJ, Comstock JP, Emanuele NV, Levin SR, Henderson W, Lee HS, VA CSDM Group. Veterans affairs cooperative study on glycemic control and complications in type II diabetes (VA CSDM). Diab Care 18 (1995) 1113-1123
2. Bech P: Well-being and quality of life for persons with diabetes. In: Staehr Johansen K, Home PD, Berger M, Massi Benedetti M, Bergrem H, Rink H V (Hrsg.): Improving Health of People with Diabetes: The "End of the Beginning" Report Fourth Meeting for Implementation of the St. Vincent Declaration a joint meeting of the Ministry of Health, Portugal, the World Health Organisation, Regional Office for Europe, and the International Diabetes Federation (Europe). Diab Nutr Metab 10 (1997) 22
3. Benecke A, Haupt E, Deutschmann R: Einflußgrößen auf die Lebensqualität bei Typ-2-Diabetikern unter drei verschiedenen antidiabetischen Monotherapien. Insulin, Sulfonylharnstoffe und Acarbose. Diab Stoffw 10 (2001) 155-164
4. Berger M, Jörgens V, Flatten G: Health care for persons with non-insulin-dependet diabetes mellitus. The German experience. Ann Int Med 124 (1996) 153-155
5. Berger M, Grüßer M, Jörgens V, Kronsbein P, Mühlhauser I, Scholz V, Venhaus A, Standl E: Behandlungs- und Schulungsprogramm für Typ-II-Diabetiker, die Insulin spritzen. Deutscher Ärzte-Verlag, Köln, Deutschland (1994)
6. Bott U, Mühlhauser I, Overmann H, Berger M: Validation of a diabetes-specific quality-of-life scale for patients with type 1 diabetes. Diab Care 21 (1998) 757-769
7. Bott U, Ebrahim S: Further development of a quality-of-life measure for IDDM patients. (Abstract) Diabetologia 41 (1998) A74
8. Bradley C, Gamsu DS for the psychological well-being working group of the WHO/IDF St. Vincent declaration action programme for diabetes: Guidelines for encouraging psychological well-being: Report of a working group of the world health organization regional office for Europe and international diabetes federation european region St. Vincent declaration action programme for diabetes. Diab Med 11 (1994) 510-516
9. Bradley C (Hrsg): Handbook of psychology and diabetes. Harwood Academic Publishers, Chur, Schweiz (1994)
10. Bradley C, Lewis KS: Measures of psychological well-being and treatment satisfaction developed from responses of people with tablet-treated diabetes. Diab Med 7 (1990) 445-451
11. Constitution of the world health organisation: In: world health organization (ed). Handbook of basic documents. 5th ed. Palais des nations, Genf, Schweiz (1952) 3-20
12. Early treatment diabetic retinopathy study group: Ophthalmology 98 (1991) Suppl. 5
13. European diabetes policy group 1998-1999: International diabetes federation, European region: A desktop guide to type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 107 (1999) 390-420
14. European diabetes policy group 1998: A desktop guide to type 1 (insulin-dependent) diabetes mellitus. Diab Med 16 (1999) 253-266
15. Franciosi M, Pellegrini F, De Berardis G, Belfiglio M, Cavaliere D, Di Nardo B, Greenfield S, Kaplan S H, Sacco M, Tognoni G, Valentini M, Nicolucci A: The Impact of Blood Glucose Self-Monitoring on Metabolic Control and Quality of Life in Type 2 Diabetic Patients. Diabetes Care 24 (2001) 1870-1877
16. Gafvels C, Lithner F, Börjeson B: Living with diabetes. Relationship to gender, duration and complications. A survey in Northern Sweden. Diab Med 10 (1993) 768-773
17. Grüßer M, Jörgens V, Berger M: Vor dem Essen Insulin. Für die flexible Behandlung des Typ-2-Diabetes mit Normalinsulin. Kirchheim-Verlag, Mainz, Deutschland (1999)
18. Grüßer M, Hartmann P, Jörgens V: Behandlungsund Schulungsprogramm für Typ-1-Diabetiker. Verlag Kirchheim, Mainz, Deutschland (1996)
19. Hanestad BR. Self-reported quality of life and the effect of different clinical and demographic characteristics in people with type 1 diabetes. Diab Res Clin Pract 19 (1993) 139-149
20. Hanestad BR, Albrektsen G: Quality of life, perceived difficulties in adherence to a diabetes regimen, and blood glucose control. Diab Med 8 (1991) 759-764
21. Hanestad BR, Hörnquist JO, Albrektsen G: Self-assessed quality of life and metabolic control in persons with insulin-dependet diabetes mellitus (IDDM). Scand J Soc Med 19 (1991) 57-65
22. Hässler R, Chantelau E, Schopen M: Plazebo-Wirkung bei der schmerzhaften diabetischen Polyneuropathie. Eine Literaturstudie. Z Allg Med (1995) 333-338
23. Head J, Fuller JH: International variation in mortality among diabetic patients: The WHO multinational study of vascular disease in diabetics. Diabetologia 33 (1990) 477-481
24. Hermanns N, Kulzer B: Die Messung von Wohlbefinden bei Diabetikern: Evaluation des Wohlbefinden-Fragebogen von Bradley. In: Kohlmann CW, Kulzer B (Hrsg.): Diabetes und Psychologie. Verlag H. Huber, Bern, Schweiz (1995) 34-50
25. Kotsanos JG, Vignati L, Huster W, Andrejasich C, Boggs MB, Jacobson AM, Marrero D, Mathias SD, Patrick D, Zalani S, Anderson J: Health-related quality-of-life-results from multinational clinical trials of insulin Lispro. Diab Care 20 (1997) 948-958
26. Krans HMJ, Porta M, Keen H (Hrsg.): World health organization regional office for Europe Copenhagen, international diabetes federation European region: diabetes care and resarch in Europe: The St. Vincent declaration action programme. Implementation document. G ital Diabetologia 15 (1995) 40-44
27. Lewis KS, Bradley C, Knight G, Boulton AJM, Ward JD: A measure of treatment satisfaction designed specially for people with insulin-dependent diabetes. Diab Med 5 (1988) 235-242
28. Liniger C, Albeanu A, Bloise D, Assal JP. The tuning fork revisited. Diab Med 7 (1990) 859-864
29. Lohr K, Bott U, Ebrahim S: Validation of a diabetes quality-of-life measure for NIDDM patients. (Abstrakt) Diabetologia 41 (1998) A256
30. Mertes B, Müller UA: Effektivität der intensivierten Insulintherapie bei jüngeren Patienten mit Typ-II Diabetes. Diab Stoffw 6 (1997) 183-187
31. Müller UA, Femerling M, Reinauer KM, Risse A, Voss M, Jörgens V, Berger M, Mühlhauser I for the ASD: Intensified treatment and education of type-1 diabetes mellitus as clinical routine: A nation-wide quality-circle experience in Germany. Diab Care 22 (1999) B29-B34
32. Müller UA, Ross IS, Klinger H, Geisenheiner S, Chantelau EA: Quality of centralized diabetes care: a population-based study in the German Democratic Republic 1989-1990. Acta Diabetol 30 (1993) 166-172
33. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diab Res Clin Pract 28 (1995) 103-117
34. Panzram G: Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30 (1987) 123-131
35. Parkerson GR, Connis RT, Broadhead WE, Patrick DL, Taylor TR, Tse CJ: Disease-specific versus generic measurement of health-related quality of life in insulin-dependent diabetic patients. Med Care 31 (1993) 629-639
36. Reichard P, Nilsson BY, Rosenqvist U: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329 (1993) 304-309
37. Rillig A, Schiel R, Braun A, Müller U: Improvement of quality of life and metabolic control of patients with typel and insulin treated type 2 diabetes mellitus - results of a population-based 10 years follow up (JEVIN). (Abstrakt) Diabetologia 45 (2002) A313
38. Rillig A, Schiel R, Braun A, Müller UA: The quality of life of patients with type 1 and type 2 diabetes mellitus and impact on quality of diabetes care - JEVIN, a population-based survey. (Abstrakt) Diabetologia 44 (2001) A258
39. Ryan CM, Geckle M: Why is learning and memory dysfunction in type 2 diabetes limited to older adults? Diab Metab Res Rev 16 (2000) 308-315
40. Sack A, Hahn W, von Lilienfeld-Toal H, Sperzel J: Zufriedenheit von Typ-I-Diabetikern mit der intensivierten Insulintherapie. Diab Stoffw 2 (1993) 299-300
41. Schiel R, Braun A, Rillig A, Ross I, Müller UA: Patient education and better general health care improve the outcome of insulin therapy - A prospective, population-based survey (JEVIN). (Abstrakt) Diabetologia 45 (2002) A314
42. Schiel R, Braun A, Rillig A, Voigt U, Müller UA: Improvement of the quality of diabetes care-JEVIN, a population based survey with 10-years-follow-up: 1989/90-1999/2000. (Abstrakt) Diabetologia 44 (2001) A247
43. Schiel R, Müller R, Leppert K, Müller UA: Lebensqualität und Stoffwechseleinstellung einer geschlossenen Population von insulinbehandelten Patienten mit Diabetes mellitus (JEVIN). Diab Stoffw 9 (2000) 327-332
44. Schiel R, Müller UA: Intensive or conventional insulin therapy in type 2 diabetic patients? A population-based study on metabolic control and quality of life (The JEVIN-trial). Exp Clin Endocrinol Diabetes 107 (1999) 506-511
45. Schiel R, Kademann A, Müller UA: Lebensqualität von Patienten mit Insulinpumpentherapie. Zprav klein farmakol farmac 12 (1998) 29-34
46. Schiel R, Müller UA, Sprott H, Schmelzer A, Hunger-Dathe W, Mertes B, Ross IS: Änderungen der Behandlungsqualität bei Patienten mit Typ-1-Diabetes fünf Jahre nach Verabschiedung der St. Vincent-Deklaration - Die JEVIN-Studie. Diab Stoffw 6 (1997) 239-244
47. Schiel R, Müller UA, Sprott H, Schmelzer A, Mertes B, Hunger-Dathe W, Ross IS: The JEVIN-trial: A population-based survey on the quality of diabetes care in Germany - 1994/95 compared to 1989/90. Diabetologia 40 (1997) 1350-1357
48. Shichiri M, Kishikawa H, Ohkubo Y, Wake N: Long-term results of the Kumamoto study on optimal diabetes control in type 2 diabetic patients. Diab Care 23 (2000) B21-B29
49. The diabetes control and complications trial research group: Effects of intensive diabetes therapy on neuropsychological function in adults in the diabetes control and complications trial. Ann Intern Med 124 (1996) 379-388
50. The diabetes control and complications trial research group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
51. Trautner C, Graf v. d. Schulenburg JM, Bott U, Keil T, Berger M: Lebensqualität bei diabetischer Neuropathie. Diab Stoffw 9 (2000) 317-321
52. UK prospective diabetes study (UKPDS) group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
53. Wändell PE, Tovi J: The quality of life of elderly diabetic patients. J Diab Compl 14 (2000) 25-30
54. Wikby A, Hörnquist JO, Stentström, Andersson PO: Background factors, long-term complications, quality of life and metabolic control in insulin dependent diabetes. Qual Life Res 2 (1993) 281-286
55. World Health Organization: Diabetes mellitus. Technical report series 727. WHO, Genf, Schweiz (1985)
56. Yki-Järvinen H, Kauppila M, Kujansuu E, Lahti J, Marjanen T, Niskanen L, Rajala S, Ryysy L, Salo S., Seppälä P, Tulokas T., Viikari J., Karjalainen J, Taskinen MR: Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus. N Engl J Med. 327 (1992) 1426-1433
57. Young MJ, Boulton AJM, Macleod AF, Williams DRR, Sonksen PH: A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 36 (1993) 150-154
58. Ziegler D, Reljanovic M, Mehnert H, Gries FA: α-Lipoic acid in the treatment of diabetic polyneuropathy in Germany: Current evidence from clinical trials. Exp Clin Endocrinol Diabetes 107 (1999) 421-430
59. Ziegler D, Hanefeld M, Ruhnau KJ, Hasche H, Lobisch M, Schütte K, Kerum G, Malessa R, the ALADIN III study group: Treatment of symptomatic diabetic polyneuropathy with the antioxidant a-lipoic acid. A 7-month multicenter randomized controlled trial (ALADIN III study). Diab Care 22 (1999) 1296-1301
60. Organization regional office for Europe and International Diabetes Federation European region St Vincent declaration action programme for diabetes. Diab Med 11 (1994) 510-551